FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics
about
On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel diseaseTacrolimus (FK506) for induction of remission in refractory ulcerative colitisDesign and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimusHistory of Nephrotic Syndrome and Evolution of its TreatmentRefined Spruce Resin to Treat Chronic Wounds: Rebirth of an Old Folkloristic TherapyTherapeutic Strategies to Treat Dry Eye in an Aging PopulationCancer wars: natural products strike backDry eye: an inflammatory ocular diseaseTargeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approachesA Structural Biology Approach Enables the Development of Antimicrobials Targeting Bacterial ImmunophilinsFrom Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials.FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae.Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding proteinMicro and nanoparticle drug delivery systems for preventing allotransplant rejectionTacrolimus in preventing transplant rejection in Chinese patients--optimizing useSolution structure of FK506 bound to FKBP-12Chemogenomics: an emerging strategy for rapid target and drug discoveryEffects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell levelThe effect of the immunosuppressant FK-506 on alternate pathways of T cell activationAntifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug actionIdentification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assayPolyenylpyrrole derivatives inhibit NLRP3 inflammasome activation and inflammatory mediator expression by reducing reactive oxygen species production and mitogen-activated protein kinase activationPhage p1-derived artificial chromosomes facilitate heterologous expression of the FK506 gene clusterCalcineurin Undergoes a Conformational Switch Evoked via Peptidyl-Prolyl IsomerizationIntravitreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in RatsThe Potential of Streptomyces as Biocontrol Agents against the Rice Blast Fungus, Magnaporthe oryzae (Pyricularia oryzae)Cyclophilin-dependent stimulation of transcription by cyclosporin ATacrolimus for the prevention and treatment of rejection of solid organ transplants.Streptomyces tsukubensis sp. nov., a producer of the immunosuppressant tacrolimus.FK506 and the role of the immunophilin FKBP-52 in nerve regeneration.Streptomyces hokutonensis sp. nov., a novel actinomycete isolated from the strawberry root rhizosphere.Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational studyFrequency-dependent and proarrhythmogenic effects of FK-506 in rat ventricular cells.Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.Chemical genetics: ligand-based discovery of gene function.dRNA-seq transcriptional profiling of the FK506 biosynthetic gene cluster in Streptomyces tsukubaensis NRRL18488 and general analysis of the transcriptomeOn the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosisTaxonomy and chemically semi-defined media for the analysis of the tacrolimus producer 'Streptomyces tsukubaensis'.Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementationScreening of small molecule interactor library by using in-cell NMR spectroscopy (SMILI-NMR).
P2860
Q21144288-BFFC22AC-F765-4E5D-BA86-361857D738A1Q24242681-3AB6C556-0703-47CC-B3F6-EC32E73D9C17Q24610099-4AFC9388-BB38-45BB-9AD0-55B6BB79551EQ26745891-4AC92CCE-F8C8-496A-843C-E567F09FCFDEQ26748522-2F2AADB1-560D-4F5C-9DA3-6CFE3005EB92Q26822610-ADF0707A-2705-42F0-A9E6-ACB17047B962Q26850074-EF980A89-4763-44E6-82E0-6ECB73088E65Q26852044-6F5C2103-2552-47CA-88E6-862D06852C26Q27009518-085A1D0A-DE1B-42EB-92C5-1D0A08303E6BQ27681063-8EC1556D-13A3-4616-83DB-B8FE7EBD0DD7Q27687259-D3E4C4F3-08A9-4F2E-9ACB-825E17CD52FDQ27931207-AE28F626-5277-4E45-B79D-4FA6B7564ED0Q27934061-9FA4E1EC-D295-4DD7-AC93-93E05760D27CQ28080720-0A0D0F46-28CC-40B7-B621-CA930692F99EQ28087131-E10F0967-061E-4A3F-BDA4-9A6FE231BBA4Q28186822-105FE3D6-BAE0-4636-8357-D5686B815E16Q28260664-D37C7733-B70C-4702-B135-08AAA2A15EABQ28316111-2BD826BF-F9F9-4B1F-823E-F162FFD91FBBQ28323723-C6B693AB-AFEB-4B7F-A089-908820C6CF78Q28343624-81B3C9FC-D962-491B-88E7-D0DC1194B871Q28476138-328FF39C-14EC-483E-BF1C-0528DC5640A5Q28534137-864312E7-772B-4722-B85B-BDFCCD8860EDQ28534635-603EB3FB-0EB3-4BAD-B5DC-CE8A4D0D8DE6Q28547077-C826A52B-A5CB-46AC-B530-4571F2F0407CQ28565470-12911981-6C6A-4474-BA0A-E519299D0A12Q28817135-2F929E09-3AF9-4E41-83EF-ABA646334C05Q29031637-20E4F5D1-CF24-4F21-B09D-922DA70E810FQ30278052-2757AB99-CE68-403B-AA33-588108C88848Q30585094-45C2A3FE-9784-4C25-8C87-C32350763BB6Q30759435-65B1A567-4D4E-4D5D-9D35-24961AB7658BQ30791186-0AEF2D4F-5516-4E0E-B19E-D6C73067EA99Q31004717-770E28D2-E760-42E8-9527-A64BFB5B860AQ31119358-231C7902-7CD6-44AB-989B-BD64A3231B77Q31418325-6B50AD4A-0AE3-4FFC-9474-99A8620B0535Q31881396-2206EA03-492E-4E9F-BB02-FFECA9781BF2Q33140504-4C61ADC4-750D-47C0-AADA-4527E41E4D10Q33346257-AEE0D893-E279-466F-BB00-3455E151A3A2Q33354365-5E2262F9-9418-4C33-8364-AC6DEAFE8AA1Q33355620-08C91C0C-AEE7-4224-8324-F7C8B1D2907DQ33440793-17489AB1-0AEE-4D68-AF7E-0CC0CAD0C5C6
P2860
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
FK-506, a novel immunosuppress ...... and biological characteristics
@ast
FK-506, a novel immunosuppress ...... and biological characteristics
@en
FK-506, a novel immunosuppress ...... and biological characteristics
@nl
type
label
FK-506, a novel immunosuppress ...... and biological characteristics
@ast
FK-506, a novel immunosuppress ...... and biological characteristics
@en
FK-506, a novel immunosuppress ...... and biological characteristics
@nl
prefLabel
FK-506, a novel immunosuppress ...... and biological characteristics
@ast
FK-506, a novel immunosuppress ...... and biological characteristics
@en
FK-506, a novel immunosuppress ...... and biological characteristics
@nl
P2093
P3181
P1476
FK-506, a novel immunosuppress ...... and biological characteristics
@en
P2093
H Hatanaka
M Hashimoto
M Nishiyama
P304
P3181
P356
10.7164/ANTIBIOTICS.40.1249
P407
P577
1987-09-01T00:00:00Z